These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29237739)

  • 1. Salt-Losing Tubulopathies in Children: What's New, What's Controversial?
    Kleta R; Bockenhauer D
    J Am Soc Nephrol; 2018 Mar; 29(3):727-739. PubMed ID: 29237739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bartter and Gitelman syndromes: Questions of class.
    Besouw MTP; Kleta R; Bockenhauer D
    Pediatr Nephrol; 2020 Oct; 35(10):1815-1824. PubMed ID: 31664557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future considerations based on the information from Barrter's and Gitelman's syndromes.
    Alfandary H; Landau D
    Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):9-13. PubMed ID: 27798456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies.
    Nozu K; Iijima K; Kanda K; Nakanishi K; Yoshikawa N; Satomura K; Kaito H; Hashimura Y; Ninchoji T; Komatsu H; Kamei K; Miyashita R; Kugo M; Ohashi H; Yamazaki H; Mabe H; Otsubo A; Igarashi T; Matsuo M
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E511-8. PubMed ID: 20810575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects.
    Seyberth HW; Schlingmann KP
    Pediatr Nephrol; 2011 Oct; 26(10):1789-802. PubMed ID: 21503667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited salt-losing renal tubulopathies manifesting as normotensive hypokalemic metabolic alkalosis.
    Singh NP; Kaur G; Prakash A
    J Assoc Physicians India; 2010 May; 58():283-4. PubMed ID: 21117345
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotype-phenotype correlations in normotensive patients with primary renal tubular hypokalemic metabolic alkalosis.
    Bettinelli A; Vezzoli G; Colussi G; Bianchetti MG; Sereni F; Casari G
    J Nephrol; 1998; 11(2):61-9. PubMed ID: 9589375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathophysiology of Bartter's and Gitelman's syndromes.
    Koulouridis E; Koulouridis I
    World J Pediatr; 2015 May; 11(2):113-25. PubMed ID: 25754753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium-related inherited tubulopathies.
    Landau D
    Cell Mol Life Sci; 2006 Sep; 63(17):1962-8. PubMed ID: 16810456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bartter-Gitelman syndromes].
    Blanchard A; Courand PY; Livrozet M; Vargas-Poussou R
    Nephrol Ther; 2020 Jul; 16(4):233-243. PubMed ID: 32622651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potassium handling in health and disease: lessons from inherited tubulopathies.
    Landau D
    Pediatr Endocrinol Rev; 2004 Dec; 2(2):203-8. PubMed ID: 16429107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological aspects of the thick ascending limb and novel genetic defects: HELIX syndrome and transient antenatal Bartter syndrome.
    Vargas-Poussou R
    Pediatr Nephrol; 2022 Feb; 37(2):239-252. PubMed ID: 33733301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter's and Gitelman's syndrome.
    Seyberth HW; Weber S; Kömhoff M
    Curr Opin Pediatr; 2017 Apr; 29(2):179-186. PubMed ID: 27906863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.
    Nuñez-Gonzalez L; Carrera N; Garcia-Gonzalez MA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary molecular changes and secondary biological problems in Bartter and Gitelman syndrome].
    Deschênes G; Feldmann D; Doucet A
    Arch Pediatr; 2002 Apr; 9(4):406-16. PubMed ID: 11998428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bartter and Gitelman syndromes.
    Zieg J; Doležel Z
    Cas Lek Cesk; 2022; 161(3-4):131-134. PubMed ID: 36100451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary renal tubular disorders.
    Chadha V; Alon US
    Semin Nephrol; 2009 Jul; 29(4):399-411. PubMed ID: 19615561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA analysis of renal electrolyte transporter genes among patients suffering from Bartter and Gitelman syndromes: summary of mutation screening.
    Urbanová M; Reiterová J; Stěkrová J; Lněnička P; Ryšavá R
    Folia Biol (Praha); 2011; 57(2):65-73. PubMed ID: 21631963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse model of type II Bartter's syndrome. II. Altered expression of renal sodium- and water-transporting proteins.
    Wagner CA; Loffing-Cueni D; Yan Q; Schulz N; Fakitsas P; Carrel M; Wang T; Verrey F; Geibel JP; Giebisch G; Hebert SC; Loffing J
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1373-80. PubMed ID: 18322017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous sequencing of 37 genes identified causative mutations in the majority of children with renal tubulopathies.
    Ashton EJ; Legrand A; Benoit V; Roncelin I; Venisse A; Zennaro MC; Jeunemaitre X; Iancu D; Van't Hoff WG; Walsh SB; Godefroid N; Rotthier A; Del Favero J; Devuyst O; Schaefer F; Jenkins LA; Kleta R; Dahan K; Vargas-Poussou R; Bockenhauer D
    Kidney Int; 2018 Apr; 93(4):961-967. PubMed ID: 29398133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.